HISTIOCYTIC NEOPLASMS
Clinical trials for HISTIOCYTIC NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new HISTIOCYTIC NEOPLASMS trials appear
Sign up with your email to follow new studies for HISTIOCYTIC NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare blood cancers: targeted pill shows promise in early trial
Disease control Recruiting nowThis study tests a drug called ulixertinib for people with histiocytic neoplasms, rare blood disorders that cause tumors. The goal is to see if the drug can shrink or control these tumors. About 38 adults will take the pill and be monitored for response and side effects.
Matched conditions: HISTIOCYTIC NEOPLASMS
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 26, 2026 06:52 UTC
-
New PET scan tracer could spot hidden cancers
Knowledge-focused Recruiting nowThis early-phase study is testing a new imaging agent called [68Ga]-pentixafor to see how well it lights up certain blood cancers and related disorders on PET/CT scans. About 30 adults with non-Hodgkin lymphoma, multiple myeloma, or histiocytic neoplasms will receive the agent an…
Matched conditions: HISTIOCYTIC NEOPLASMS
Phase: EARLY_PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 06:56 UTC